Loading...
XSHG
603883
Market cap1.48bUSD
Oct 08, Last price  
13.28CNY
Name

LBX Pharmacy Chain JSC

Chart & performance

D1W1MN
XSHG:603883 chart
P/E
26.39
P/S
0.45
EPS
0.50
Div yield, %
1.69%
Shrs. gr., 5y
7.53%
Rev. gr., 5y
9.75%
Revenues
22.24b
-0.54%
2,467,038,1172,841,634,8833,321,294,6443,942,877,2954,568,482,8616,094,431,2757,501,432,3269,471,089,28811,663,176,22913,966,699,24015,695,664,14720,175,519,30322,437,489,01222,357,610,19522,236,615,347
Net income
382m
-26.44%
98,963,320125,036,547160,720,726202,382,081240,501,810296,895,435370,800,158435,036,736508,711,909621,090,283669,236,722784,961,520929,023,131519,063,405381,846,593
CFO
3.14b
+55.08%
132,619,219148,854,663136,517,629247,144,683257,149,257313,257,834492,131,548913,025,5571,032,537,1771,447,477,8502,298,296,5442,314,315,0092,729,838,9472,026,458,7973,142,633,749
Dividend
Sep 10, 20260.3 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

LBX Pharmacy Chain Joint Stock Company, headquartered in Changsha, China, oversees a substantial network of retail pharmacies throughout the country. Its operations span 21 distinct provincial markets across China, encompassing regions such as Hunan, Jiangsu, Gansu, Shaanxi, Guangxi, Anhui, Zhejiang, Inner Mongolia, Hubei, Tianjin, Henan, Shanghai, Shandong, Guangdong, Hebei, Beijing, Jiangxi, Ningxia, Sichuan, Fujian, and Guizhou. The company, which commenced operations in 2001, was originally incorporated under the name Laobaixing Pharmacy Chain Joint Stock Company.

Key people

Li Wang
Executive President · since 2019
Zhan Shi
Vice Chairman of the Board
Xingwu Liu
Vice President · since 2016
Aimin Tang
Vice President
Yu Zhang
Secretary of the Board
Kunting Mo
Director
Bjarne Mumm
Director
Peter Zuellig
Director
Chang'en Ouyang
Independent Director
Jiayao Xu
Independent Director
Haiyu Yang
Independent Director
IPO date
Apr 23, 2015
Employees
Domiciled in
CN
Incorporated in
CN
Headquarters & legal address
长沙市开福区青竹湖路808号
长沙市, HN 100000
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT